News
“In general, transmission in Europe is driven by suboptimal vaccination coverage for measles in a number of EU/EEA countries.
Severe Acute Respiratory Syndrome (SARS) is a disease that first appeared in humans in November 2002. Infection initially brings flu-like symptoms including fever and fatigue, but it then attacks ...
1d
News-Medical.Net on MSNNasal protein levels may predict COVID-19 riskAs compared to controls, elevated nasal levels of ACE2 and TMPRSS2 were associated with a 3.6-fold increased risk of SARS-CoV ...
In mechanically ventilated patients with ARDS, the treatment effect of neuromuscular blockade on mortality likely varies with respiratory elastance.
17d
News-Medical.Net on MSNDoes COVID-19 affect heart rate variability after recovery?Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...
Otto and co-author Sean Edgerton, a PhD student focused on genomics and infectious diseases at the University of British ...
No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...
The newest one to make people sick causes COVID-19, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first record of illness linked to SARS-CoV-2 was in China in ...
SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) are serious infectious respiratory diseases that are caused by members of a class of viruses known as coronaviruses ...
VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat ...
Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Inhaled sevoflurane significantly reduced ventilator-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results